ICU MEDICAL INC (ICUI) Stock Fundamental Analysis
NASDAQ:ICUI - Nasdaq - US44930G1076 - Common Stock - Currency: USD
Overall ICUI gets a fundamental rating of 4 out of 10. We evaluated ICUI against 187 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of ICUI get a neutral evaluation. Nothing too spectacular is happening here. ICUI has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
ICUI had positive earnings in the past year.
ICUI had a positive operating cash flow in the past year.
In multiple years ICUI reported negative net income over the last 5 years.
Of the past 5 years ICUI 4 years had a positive operating cash flow.
1.2 Ratios
ICUI's Return On Assets of -2.24% is fine compared to the rest of the industry. ICUI outperforms 70.59% of its industry peers.
ICUI's Return On Equity of -4.71% is fine compared to the rest of the industry. ICUI outperforms 71.66% of its industry peers.
ICUI's Return On Invested Capital of 2.76% is fine compared to the rest of the industry. ICUI outperforms 70.59% of its industry peers.
ICUI had an Average Return On Invested Capital over the past 3 years of 1.36%. This is significantly below the industry average of 7.89%.
The 3 year average ROIC (1.36%) for ICUI is below the current ROIC(2.76%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.24% | ||
| ROE | -4.71% | ||
| ROIC | 2.76% |
ROA(3y)-1.71%
ROA(5y)1.06%
ROE(3y)-3.65%
ROE(5y)0.24%
ROIC(3y)1.36%
ROIC(5y)3.41%
1.3 Margins
ICUI's Operating Margin of 5.25% is fine compared to the rest of the industry. ICUI outperforms 70.59% of its industry peers.
ICUI's Operating Margin has declined in the last couple of years.
ICUI's Gross Margin of 35.11% is on the low side compared to the rest of the industry. ICUI is outperformed by 70.59% of its industry peers.
ICUI's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.25% | ||
| PM (TTM) | N/A | ||
| GM | 35.11% |
OM growth 3Y-26.21%
OM growth 5Y-22.36%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.48%
GM growth 5Y-1.46%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ICUI is destroying value.
Compared to 1 year ago, ICUI has more shares outstanding
Compared to 5 years ago, ICUI has more shares outstanding
Compared to 1 year ago, ICUI has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.07 indicates that ICUI is not a great score, but indicates only limited risk for bankruptcy at the moment.
ICUI's Altman-Z score of 2.07 is in line compared to the rest of the industry. ICUI outperforms 59.89% of its industry peers.
The Debt to FCF ratio of ICUI is 12.69, which is on the high side as it means it would take ICUI, 12.69 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 12.69, ICUI is in the better half of the industry, outperforming 73.80% of the companies in the same industry.
ICUI has a Debt/Equity ratio of 0.75. This is a neutral value indicating ICUI is somewhat dependend on debt financing.
The Debt to Equity ratio of ICUI (0.75) is worse than 72.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.75 | ||
| Debt/FCF | 12.69 | ||
| Altman-Z | 2.07 |
ROIC/WACC0.33
WACC8.4%
2.3 Liquidity
A Current Ratio of 2.59 indicates that ICUI has no problem at all paying its short term obligations.
ICUI has a Current ratio (2.59) which is comparable to the rest of the industry.
A Quick Ratio of 1.52 indicates that ICUI should not have too much problems paying its short term obligations.
ICUI's Quick ratio of 1.52 is in line compared to the rest of the industry. ICUI outperforms 42.78% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.59 | ||
| Quick Ratio | 1.52 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 16.72% over the past year.
The Earnings Per Share has been decreasing by -5.28% on average over the past years.
Looking at the last year, ICUI shows a small growth in Revenue. The Revenue has grown by 7.22% in the last year.
ICUI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.47% yearly.
EPS 1Y (TTM)16.72%
EPS 3Y-5.58%
EPS 5Y-5.28%
EPS Q2Q%79.17%
Revenue 1Y (TTM)7.22%
Revenue growth 3Y21.86%
Revenue growth 5Y13.47%
Sales Q2Q%8.49%
3.2 Future
ICUI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.81% yearly.
ICUI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.68% yearly.
EPS Next Y8.83%
EPS Next 2Y15.81%
EPS Next 3Y15.83%
EPS Next 5Y16.81%
Revenue Next Year-4.99%
Revenue Next 2Y-2.87%
Revenue Next 3Y-0.13%
Revenue Next 5Y2.68%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 19.40, which indicates a rather expensive current valuation of ICUI.
81.28% of the companies in the same industry are more expensive than ICUI, based on the Price/Earnings ratio.
ICUI is valuated rather cheaply when we compare the Price/Earnings ratio to 27.45, which is the current average of the S&P500 Index.
ICUI is valuated correctly with a Price/Forward Earnings ratio of 16.24.
Based on the Price/Forward Earnings ratio, ICUI is valued cheaper than 82.35% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.90, ICUI is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.4 | ||
| Fwd PE | 16.24 |
4.2 Price Multiples
82.89% of the companies in the same industry are more expensive than ICUI, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, ICUI is valued cheaper than 83.96% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 27.46 | ||
| EV/EBITDA | 13.52 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ICUI does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as ICUI's earnings are expected to grow with 15.83% in the coming years.
PEG (NY)2.2
PEG (5Y)N/A
EPS Next 2Y15.81%
EPS Next 3Y15.83%
5. Dividend
5.1 Amount
No dividends for ICUI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
135.44
-0.74 (-0.54%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners101.8%
Inst Owner Change1.53%
Ins Owners1.14%
Ins Owner Change1.25%
Market Cap3.33B
Analysts83.64
Price Target192.02 (41.77%)
Short Float %4.59%
Short Ratio4.25
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)35.66%
Min EPS beat(2)31.74%
Max EPS beat(2)39.58%
EPS beat(4)4
Avg EPS beat(4)37.3%
Min EPS beat(4)24.67%
Max EPS beat(4)53.22%
EPS beat(8)8
Avg EPS beat(8)27.42%
EPS beat(12)11
Avg EPS beat(12)19.81%
EPS beat(16)15
Avg EPS beat(16)16.98%
Revenue beat(2)2
Avg Revenue beat(2)2.62%
Min Revenue beat(2)2.15%
Max Revenue beat(2)3.09%
Revenue beat(4)4
Avg Revenue beat(4)2.15%
Min Revenue beat(4)0.5%
Max Revenue beat(4)3.09%
Revenue beat(8)5
Avg Revenue beat(8)-0.76%
Revenue beat(12)6
Avg Revenue beat(12)-0.81%
Revenue beat(16)9
Avg Revenue beat(16)-0.06%
PT rev (1m)-0.13%
PT rev (3m)-2.46%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.21%
EPS NY rev (1m)0%
EPS NY rev (3m)0.1%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-7.79%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.78%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.4 | ||
| Fwd PE | 16.24 | ||
| P/S | 1.38 | ||
| P/FCF | 27.46 | ||
| P/OCF | 15.9 | ||
| P/B | 1.68 | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.52 |
EPS(TTM)6.98
EY5.15%
EPS(NY)8.34
Fwd EY6.16%
FCF(TTM)4.93
FCFY3.64%
OCF(TTM)8.52
OCFY6.29%
SpS98.34
BVpS80.77
TBVpS-7.48
PEG (NY)2.2
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.24% | ||
| ROE | -4.71% | ||
| ROCE | 3.49% | ||
| ROIC | 2.76% | ||
| ROICexc | 3% | ||
| ROICexgc | 8.54% | ||
| OM | 5.25% | ||
| PM (TTM) | N/A | ||
| GM | 35.11% | ||
| FCFM | 5.02% |
ROA(3y)-1.71%
ROA(5y)1.06%
ROE(3y)-3.65%
ROE(5y)0.24%
ROIC(3y)1.36%
ROIC(5y)3.41%
ROICexc(3y)1.47%
ROICexc(5y)4.61%
ROICexgc(3y)4.17%
ROICexgc(5y)7.18%
ROCE(3y)1.72%
ROCE(5y)4.32%
ROICexcg growth 3Y-18.09%
ROICexcg growth 5Y-16.18%
ROICexc growth 3Y-37.66%
ROICexc growth 5Y-28.8%
OM growth 3Y-26.21%
OM growth 5Y-22.36%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.48%
GM growth 5Y-1.46%
F-Score5
Asset Turnover0.58
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.75 | ||
| Debt/FCF | 12.69 | ||
| Debt/EBITDA | 4.38 | ||
| Cap/Depr | 41.32% | ||
| Cap/Sales | 3.64% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 61.57% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.59 | ||
| Quick Ratio | 1.52 | ||
| Altman-Z | 2.07 |
F-Score5
WACC8.4%
ROIC/WACC0.33
Cap/Depr(3y)41.42%
Cap/Depr(5y)66.41%
Cap/Sales(3y)4.1%
Cap/Sales(5y)5.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.72%
EPS 3Y-5.58%
EPS 5Y-5.28%
EPS Q2Q%79.17%
EPS Next Y8.83%
EPS Next 2Y15.81%
EPS Next 3Y15.83%
EPS Next 5Y16.81%
Revenue 1Y (TTM)7.22%
Revenue growth 3Y21.86%
Revenue growth 5Y13.47%
Sales Q2Q%8.49%
Revenue Next Year-4.99%
Revenue Next 2Y-2.87%
Revenue Next 3Y-0.13%
Revenue Next 5Y2.68%
EBIT growth 1Y157.49%
EBIT growth 3Y-10.08%
EBIT growth 5Y-11.9%
EBIT Next Year38.33%
EBIT Next 3Y19.87%
EBIT Next 5Y18.27%
FCF growth 1Y210.75%
FCF growth 3Y-15.14%
FCF growth 5YN/A
OCF growth 1Y1169.23%
OCF growth 3Y-8.63%
OCF growth 5Y14.9%